Targeting ferroptosis as a promising therapeutic strategy for ischemia-reperfusion injury

Y Pan, X Wang, X Liu, L Shen, Q Chen, Q Shu - Antioxidants, 2022 - mdpi.com
Ischemia-reperfusion (I/R) injury is a major challenge in perioperative medicine that
contributes to pathological damage in various conditions, including ischemic stroke …

[HTML][HTML] An overview of renal metabolomics

S Kalim, EP Rhee - Kidney international, 2017 - Elsevier
The high-throughput, high-resolution phenoty** enabled by metabolomics has been
applied increasingly to a variety of questions in nephrology research. This article provides …

A combined epidemiologic and metabolomic approach improves CKD prediction

EP Rhee, CB Clish, A Ghorbani… - Journal of the …, 2013 - journals.lww.com
Metabolomic approaches have begun to catalog the metabolic disturbances that accompany
CKD, but whether metabolite alterations can predict future CKD is unknown. We performed …

[HTML][HTML] RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival

A Lau, S Wang, J Jiang, A Haig, A Pavlosky… - American Journal of …, 2013 - Elsevier
Kidney transplant injury occurs with ischemia and alloimmunity. Members of the receptor
interacting protein kinase family (RIPK1, 3) are key regulators of “necroptosis,” a newly …

[HTML][HTML] The kynurenine pathway in acute kidney injury and chronic kidney disease

HN Wee, JJ Liu, J Ching, JP Kovalik… - American Journal of …, 2021 - karger.com
Background: The kynurenine pathway (KP) is the major catabolic pathway for tryptophan
degradation. The KP plays an important role as the sole de novo nicotinamide adenine …

Increased indoleamine 2, 3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link …

JC Schefold, JP Zeden, C Fotopoulou… - Nephrology Dialysis …, 2009 - academic.oup.com
Abstract Background. Tryptophan (Trp) is catabolized by indoleamine 2, 3-dioxygenase
(IDO). Changes in Trp metabolism and IDO activity in chronic kidney disease (CKD) have …

Tryptophan metabolism in patients with chronic kidney disease secondary to type 2 diabetes: relationship to inflammatory markers

S Debnath, C Velagapudi, L Redus… - International …, 2017 - journals.sagepub.com
Objective: Type 2 diabetes (T2D) is the primary case of chronic kidney disease (CKD).
Inflammation is associated with metabolic dysregulation in patients with T2D and CKD …

[PDF][PDF] Orchestration of tryptophan‐kynurenine pathway, acute decompensation, and acute‐on‐chronic liver failure in cirrhosis

J Clària, R Moreau, F Fenaille, A Amorós, C Junot… - …, 2019 - Wiley Online Library
Systemic inflammation (SI) is involved in the pathogenesis of acute decompensation (AD)
and acute‐on‐chronic liver failure (ACLF) in cirrhosis. In other diseases, SI activates …

Tryptophan: from diet to cardiovascular diseases

NJ Melhem, S Taleb - International Journal of Molecular Sciences, 2021 - mdpi.com
Cardiovascular disease (CVD) is one of the major causes of mortality worldwide.
Inflammation is the underlying common mechanism involved in CVD. It has been recently …

Kynurenine pathway in kidney diseases

I Zakrocka, W Załuska - Pharmacological Reports, 2022 - Springer
Kidney diseases have become one of the most common health care problems. Due to a
growing number of advanced aged patients with concomitant disorders the prevalence of …